Vaccines and Immune Response

About Immune Response 2019 Conference

It is our immense pleasure to welcomes every one of the members over the globe to participate in the International Conference on Vaccines and Immune Response during June 17-18, 2019 in Dubai, UAE and highlights the theme "Next Generation Vaccine; Research, Development and Challenges" which includes various research findings about Vaccines and Immunology.

IMMUNE RESPONSE 2019 is planned with the theme “Next Generation Vaccine; Research, Development and Challenges” ME Conference coordinates 1000+ Global Events comprehensive of 300+ Conferences, 500+ Upcoming and Previous Symposiums and Workshops in USA, Europe & Asia with support from 1000 more scientific societies and publishes 700+ Open access journals which contains over 30000 eminent personalities, reputed scientists as editorial board members.

Vaccines Conference brings together scientists, public health professional, vaccine researchers and other key stakeholders to discuss progress and challenges in Vaccines research and development and implementation as identified in the universal Vaccines accomplishment. The aim of the conference is to provide an international platform for discussion and debate among Vaccines research and development providers, policy makers, academics and researchers on strategies and initiatives to achieve transformational and sustainable development in Vaccines research and development in local and global contexts.

On behalf of IMMUNE RESPONSE 2019, we invite you to take this opportunity to join us for academic exchange and visit the city of Dubai, UAE.

Why to attend?

Immune Response 2019 is aimed to give an opportunity that with scholars from around the globe focused on learning about Vaccines & Immunology and its advances, Development and Challenges; this is the best opportunity to reach the largest assemblage of contributors from the Vaccines & Immunology community. Lead overviews, circulate data, meet with existing and potential researchers, make a sprinkle with new vaccinations and immunizations improvements, and get name acknowledgement at this occasion. Widely acclaimed speakers, the latest systems, improvements, and the most up to date refreshes in Vaccinology/ Immunology are signs of this gathering. World-renowned speakers, the best current researches, developments, challenges and the newest updates in Vaccines & Immunology are hallmarks of this conference.

Target audience:

• Researchers & Scientists related to Vaccine R&D
• Directors, CEOs, Presidents and Vice Presidents
• Deans and Professors
• Vaccinology/Immunology University Faculty
• Associations and Societies related to Vaccine R&D
• Medical Schools/Colleges
• Nursing Schools/Colleges
• Vaccination Programme Organising Government and Non-government Organisations
• Business Entrepreneurs
• Data Management Companies
• Medical Devices Manufacturing Companies
• Vaccine Manufacturing Companies
• Vaccine Developers and Investigators
• Machinery Manufacturing Companies.

Conference Highlights:

• Vaccines
• Immunology
• Vaccine Types
• Vaccines Research & Development
• Vaccines & Immunizations
• Vaccine Production
• Human Vaccines
• Flu Vaccines
• Cancer Vaccines
• HIV/AIDS Vaccines
• HPV Vaccines
• Viral Vaccines
• DNA Vaccines
• Plant Derived Vaccines
• Mosquito-Borne Diseases-Vaccines
• Veterinary Vaccination
• Vaccine Safety
• Immune Mediated Vaccines
• Vaccines Clinical Trials
• Antibodies Research

Sessions/Tracks

Vaccines

Nowadays vaccination is a very important part of public health and family. Vaccination is the essential part in our life for keeping us healthy and keeps us safe. Vaccines prevent the spread of chronic, contagious, deadly and dangerous diseases. It helps us to fight against many chronic and contagious diseases like polio, mumps, HIV, HPV, smallpox, cancer, Influenza, etc. The eradication of smallpox is exactly achieved by the vaccine discovery. A vaccine contains a disease-causing microorganisms like viruses and bacteria. Those agents are present in the vaccine when vaccinated stimulate the immune system and it gets recognized and the infection eliminates by the body’s immune system. But vaccines remain elusive for the treatment of many important diseases like HIV, Ebola, Malaria, Herpes etc. This Conference brings out the knowledge about the recent research, development and future aspects of Vaccines.

• Vaccine monitoring and storage
• Vaccine development
• Next generation vaccines research
• Vaccine ingredients
• HIV and HPV vaccines
• TB and Malaria vaccines

Immunology

Immunology is a branch of biology that covers the study of the immune system and is a very important branch of the medical and biological sciences. The immune system protects us from pathogen through various lines of defense. Mainly the function of the immune system is to fight against the antigens that enter into the body through various paths. It also can recognize the non-self and self-antigens. Basically, the molecular and cellular components build up the immune system. The function of these components divided into innate and adaptive immunities. The adaptive immune system mediates the humoral and cell-mediated immune responses. The immunoglobulin molecules play a significant role in the immune system by neutralizing the antigens. 

• Immunity types
• Cancer Biology and DNA Damage Response
• Cancer Immunotherapy
• Immunodeficiency
• Nutritional Immunology
• Transplant Immunology
• Veterinary Immunology

Vaccine Types

The Vaccines type includes Inactivated Vaccines, Recombinant Vaccines, Live Attenuated Vaccines, Toxoid vaccines, Subunit Vaccines, and Conjugate Vaccines. Within all these vaccines, the Attenuated Vaccines were first developed against the viruses. The first Vaccine developed using live attenuated virus and that was Rabies Vaccine. Generally Inactivated Viruses contained killed microorganisms. U.S Childhood Immunization, they recently recommended the Live, Attenuated Vaccines for MMR vaccine. The recombinant vaccine is produced by utilizing the gene segment from the protein of a disease-causing organism.

• Live, Attenuated vaccines
• Toxoid vaccines
• Conjugate vaccines
• Inactivated vaccines
• Subunit vaccines

Vaccines Research & Development

The revelation of vaccinations has activated the nearby demolition of a pair of basic diseases and has enormously influenced prosperity for a decently insignificant exertion. WHO’s Initiative for Vaccine Research (IVR) facilitates vaccine research and development (R&D) against pathogens with significant disease and economic burden, with a particular focus on low and middle earnings countries. Maximum antibodies which being utilized today were created by frameworks that were initiated more than 100 years ago and don't address the greatest limit of the field. The introduction of innate structure has controlled quick advances in counter acting agent development and is as of now provoking to the entry of new things in the business focus.

• Recent focus in virology
• Retroviral diseases in Middle East, Asia & Africa
• Vectors / drug delivery / adjuvants
• Modified medicine
• Vaccines manufacturing & bioprocessing

Vaccines & Immunizations

Vaccination is the organization of antigenic material to animate a person's resistant framework to create versatile insusceptibility to a pathogen. Immunizations can improve or prevent powerful illness. Vaccines stimulate the body’s own immune system to protect the person against subsequent disease or infection. The adequacy of vaccination has been generally examined and after then confirmed. Vaccination is the best technique for killing powerful diseases; across the board invulnerability because of immunization are to a great extent in charge of the overall destruction of smallpox and the end of maladies, for example measles, polio and lockjaw from a significant part of the world.

• Combinationvaccines and plant based vaccines
• Recombinant vector based
• Therapeutic vaccination for auto immune diseases
• Vaccines against vector-borne diseases
• Vaccination in new-borns, pregnancy and the elderly populations
• Immunology
• Age-specific immune response to vaccination

Vaccine Production

An antibody is a natural readiness that gives dynamic acquired immunity to a particular ailment. An antibody consistently contains an administrator that takes after an ailment causing microorganism and is normally produced using executed types of the organism, its toxic substances or one of its surface proteins. The administrator strengthens the body's immune system to perceive the specialist as a danger, destroy it, and perceive and devastate any of these microorganisms that it later experiences. Antibodies can be supportive or prophylactic. The association of vaccination or immunization is called inoculation. The viability of inoculation has been extensively considered and confirmed.

• Vaccines awareness
• Business development
• Attenuated vaccines
• T-cell receptor peptide vaccines
• Cost effective production

Human Vaccines

A vaccine is an inactivated form of bacteria/ virus or killed microorganisms that is injected into the body to simulate an actual infection. Because the injected microorganisms are 'killed or dead,' they don't cause a person to become sick. Instead of vaccines stimulate also an immune response by the body that will fight off that type of disease. It covers non-infectious disease targets and infectious disease targets. The process for the Vaccine-mediated protection is a complex challenge. Presently available vaccines have largely been settled empirically, with little or no understanding on how they activate the immune system. Their initial protective efficacy is mainly conferred by the induction of antigen-specific antibodies. However, there is more to antibody-mediated protection than the highest of immunization-induced antibody titers.

• Rubella vaccine
• Influenza vaccines
• Cholera vaccine
• Chickenpox vaccine
• Rotavirus vaccine
• Measles vaccines

Flu Vaccines

Basically, influenza vaccines are those vaccines that protect against infection by influenza viruses. The development phase for a new version of vaccine basically happens for twice a year, as the influenza virus rapidly changes. Influenza is a dangerous and chronic disease that leads to even death in some serious conditions. As per the survey, about millions of people will get flu every year and for this about tens of thousands of die from flu related diseases. Taking annual systematic flu vaccine is the only way to decrease the risk of getting infection with seasonal flu and it can be can spreading to other people.

• Flu vaccines recent research
• Flu vaccines mechanisms
• Flu vaccine types
• Flu vaccine  characterization
• Flu shots pros and cons

Cancer Vaccines

Cancer vaccines enhance the immune system's natural ability to diagnosis and destroy things that are foreign and potentially harmful to the body. A strong, healthy immune system is able to recognize antigens (substances on the surface of cells that are not regularly part of the body) and attack them, typically eliminating them. The immune system is then left with a “memory” that helps it to react to those antigens later on. The cancer treatment vaccine takes advantage of the immune system’s reacts to antigens. Even cancer cells having some specific molecules on their cell surface, those are not present on the healthy cells. When injected into a person, those specific molecules act as antigens, which stimulate the immune system to distinguish and destroy those cancer cells that have these molecules on their cell surface. Most cancer vaccines additionally contain adjuvants. Cancer vaccines are two types. They are Preventive vaccines in nature.

• Cancer therapy and clinical cancer research
• Anti-cancer drugs and delivery
• Cancer cell diagnosis, biology and applied research

HIV/AIDS Vaccines

An AIDS vaccine does not yet exist, but efforts to build up an antibody or vaccine against HIV, the virus that causes AIDS, have been in a progress for many years. An HIV vaccine could be effective in both of two different ways. A “preventive” vaccine would stop HIV contamination occurring altogether, whereas a “therapeutic” vaccine would not stop contamination, but would delay or prevent illness in people who do become contaminated, and might also decrease the dangerous factor of them transmitting the virus to other individuals. In spite of the fact that a preventive vaccine would be ideal, a therapeutic vaccine also can be highly beneficial. The fundamental thought behind all HIV vaccines is to encourage the human immune system to fight against HIV.

Historically, vaccines have been our best weapon against the world’s deadliest contagious diseases, including polio, small pox, yellow fever and measles. Unfortunately, currently we do not have a vaccine for HIV. The virus has unique ways of avoiding the immune system, and the human body seems incapable of mounting an effective immune response against it. As a result, researchers do not have a reasonable picture of what is needed to provide protection against HIV.

• HIV research and therapy
• HIV vaccine strategies
• B cell-based vaccines
• T cell-based vaccines
• Viral vaccine vectors
• Innate & mucosal immunity
• Challenges facing AIDS vaccine development
• Preventive HIV vaccines
• Recombinant vector vaccine
• Age acceleration effects due to HIV infection

HPV Vaccines

Human Papillomavirus (HPV) vaccine is not a live or inactivated vaccine. HPV is the most unstated sexually-transmitted disease in the US. There are a couple of types of hepatitis diseases including types A, B, C, D, E, and possibly G. Types A, B, and C are the most generally perceived. All hepatitis diseases can be turned into extreme hepatitis.

HPV vaccine mainly protects against four major types. These include two types that cause about 90% of genital warts and two types that cause about 70% of cervical cancer. The usage of HPV vaccine can prevent most of the genital warts and in most cases of cervical cancer. Protection from HPV vaccination is expected to gives a long-term result. But vaccinated women still needed the cervical cancer screening because the vaccine does not defend against or protect from all HPV types that cause cervical cancer.

• HPV vaccines for men
• HPV vaccines for women
• Advances in HPV vaccine
• HPV infection & cancer
• Hepatitis viruses & co-infection with HIV
• HPV & Hepatitis vaccines current updates
• HPV vaccines safety, prevention
• Global HPV vaccine market analysis

Viral Vaccines

Most of vaccines against viral contamination are effective at preventing disease. However, vaccines are not 100% effective for a number of reasons, after vaccination also the reactions can occur.

It is really difficult for many of us today to appreciate the risks of childhood viral infections.

Most of the vaccines in use against viruses are extremely effective at preventing disease. However, for some of reasons, they can fail:

1. The vaccine turns to inactive due to incorrect storage, if used over its expiry date, or if it’s incorrectly administered.
2. Individuals unpredictably fail to produce a sufficient immune reaction or response to the vaccine.
3. Vaccine immunity “fades” after some time.

• Viral vaccines
• Rotavirus
• Inactivated vaccine
• Rubella virus
• Recombinant vaccines
• Bacterial Vaccines
• Stomach flu
• Viral pneumonia
• Viral hepatitis

DNA Vaccines

DNA vaccines are the newest type of vaccine and consist of only a DNA molecule encoding the antigen(s) of interest and, possibly, costimulatory   molecules such as cytokines. DNA immunization is a new technique used to efficiently stimulate humoral and cellular immune responses to protein antigens. . DNA vaccines are third generation vaccines and are made up of a small, circular piece of bacterial DNA.DNA vaccination is a technique for protecting an organism against disease by injecting it with genetically engineered DNA to build an immunological response. The single direct injection of genetic material into a living host causes a small amount of its cells to produce the introduced gene products. This improper gene expression within the host has important immunological consequences, resulting in the specific immune activation of the host against the gene delivered antigen.

• DNA vaccination
• Delivery methods
• Next generation DNA Vaccines
• Recombinant vaccines

Plant Derived Vaccines

Plant-based immunizations are recombinant protein subunit vaccines. Ideally, the choice of plant species used to create the chosen antigen should allow for oral medication in the form of an edible vaccine. To date, the most developed human vaccine projects have effectively completed phase I clinical trials, and animal vaccine projects have specified promising data in early phase trials targeting specific animal species.

• Molecular level of Plant based Vaccine
• Plant based Vaccine against Virus
• Disadvantages of Plant Based Vaccines
• Direct Gene Delivery Method
• Production of Plant based Vaccine

Mosquito-Borne Diseases-Vaccines

Mosquito borne appealing infections are among vital gathering of diseases around the world. Immunization is accessible for some tropical mosquito-borne infections, particularly for Japanese encephalitis contamination and yellow fever. There are additionally a few endeavours’ to grow new vaccinations for the other mosquito-borne infections, for example dengue fever, jungle disease and West Nile infection contamination.

• Protozoa
• Viruses
• Progress and challenges
• Helminthiasis

Veterinary Vaccination

Veterinary immunization have had, and continue having, a critical part in guaranteeing animal fortune and general affluence, diminishing animal persisting, permitting capable era of food animals to support the healthy human and hugely diminishing the prerequisite for hostile to microbial to treat nourishment and amigo animals. Rabies antibodies for domestic unit animals and untamed life have about abstained from human rabies in made countries.

• Veterinary vaccines for animals
• Pet vaccines and vaccinations
• Animal immunizations
• Innovations in animal vaccines
• Others

Vaccine Safety

Vaccines are the best protection we have against preventable, serious and sometimes deadly contagious diseases. Vaccines are some of the safest medicinal products available, but like any other medicinal product, there may be health risk. Accurate information about the value of vaccines as well as their probable side-effects helps people to make informed decisions about vaccination.

• Vaccine safety communication
• Factors Influencing Vaccine efficacy
• Vaccine Storage, Administration & Handling

Immune Mediated Vaccines

Patients with safe mediated incendiary ailments (for example, IBD, RA or psoriasis, are at increased risk of contamination, in part in light of the malady itself, however for the most part in light of treatment with immunomodulatory or immunosuppressive medications. Regardless of their raised hazard for vaccination preventable disease, immunization scope in IMID patients is shockingly low.

• Vaccines for immunodeficiency diseases
• Innate immunity and diabetes vaccines
• Vaccines for autoimmune skin disorders
• Vaccination strategy in patients with IMID

Vaccines Clinical Trials

The development of human vaccines keeps on depending on the use of animals for research. Administrative specialists require novel vaccine candidates to undergo preclinical assessment in animal models before being permitted to enter the clinical phase in human subjects. However, the ultimate goal of a new vaccine is to instruct the immune system to produce an effective immune response against the pathogen of interest, and no alternatives to live animal use at present exist for evaluation of this reaction.

• Innovations and clinical trials in vaccination
• Research and development of viral vaccines, including field trials
• Diagnostic and clinical applications

Antibodies Research

Immunizer Genetic Engineering and Therapeutics meeting combined a widespread scope of members who were refreshed on the most recent advances in counter acting agent innovative work. Composed by IBC Life Sciences, the get-together is the annually meeting of The Antibody Society, which fills in as the logical support. Preconference workshops on 3D representing and outline of clonal ancestries were highlighted.

• Antibody biology & engineering
• Genetics and epigenetics of the immune system
• Non antibody immunity
• Antibodies and neuroscience

Market Analysis

Vaccines Conferences advisory board invites all the participants across the world to attend “International Conference on Vaccine and Immune Response” going to be held during February 11-12, 2019 in Dubai, UAE. The Theme of the conference is "Next Generation Vaccine; Research, Development and Challenges" will explore the advances in Vaccines and Immune Response.

This conference could be an unique event that brings along a International and novel mixture of huge and medium cognizance on vaccines and immune response, leading universities engendering the conference an ideal platform to apportion expertise, foster collaborations across trade and globe, and assess elevating technologies across the world.

Vaccination is a key to abolish the diseases. It is the subject for the researchers, scientists, professionals who looks beyond the clinical prospects. Traditional approaches to vaccine design were to inactivate the human pathogen or an equivalent animal homologue, Vaccinology can define as, the science of vaccine research, development and how the immune system responds to vaccines, as well as includes continuous evaluation of immunization programs and vaccine safety and efficacy, and observation epidemiology of vaccine-preventable diseases. This chapter provides a brief overview of some of the main concepts of Vaccinology and immunology as they relate to vaccination. Vaccine and Immune Response 2019 amasses all the extroverts under one roof of current advances.

Scope and Importance:

The rising pervasiveness of a few diseases and the rise of a few new illnesses are relied upon to empower the main players in the market for the advancement of novel and successful antibodies and medications. This is anticipated to upgrade the development of the worldwide vaccinations showcase in the following couple of years.

As indicated by the statistical surveying study that has been as of late distributed by Transparency Market Research, global revenue for vaccine technologies was nearly $31.8 billion in 2011. This market is expected to increase from $33.6 billion in 2012 to $43.4 billion in 2017 at a compound annual growth rate (CAGR) of 5.3%.

Why in Dubai:

Dubai has evolved into a key player in the global economy and most crowded city in the United Arab Emirates (UAE). Dubai aspires to boost its position by embellishing its standing as a universal business center to be amidst the top 5 centers for finance, trade, logistics, and tourism. Dubai’s proclamation as the Capital of Islamic Economy is a significant phase in identifying Dubai as one of the leading economic centers. This theme targets inspiring Dubai to manufactures industries for medicines such as antibiotics, cardiovascular, painkillers, food supplements, vitamins and anti-allergic formulations and others Environment. Dubai investment in Globalpharma was well organized, as they profited on the rapid growth in the pharmaceutical sector in the region.  In addition, the theme features the significance of a varied set of value-added commercial actions that would improve Dubai’s economic flexibility and allow it to ingest internal and external impacts.

Past Conference Report

Euro Vaccines 2018

The 31^st Euro Global Summit and Expo on Vaccines & Vaccination hosted by Conference series LLc Ltd during June 14-16, 2018 at TRYP BARCELONA AEROPUERTO, Barcelona, Spain with a theme “Roadmap on the future of Vaccines Research” and was a great success where eminent keynote speakers, Speakers, Delegates and Poster Presenters from various reputed companies and Universities made their resplendent presence and addressed the gathering.  

Euro Vaccines 2018 witnessed an amalgamation of peerless speakers who enlightened the crowd with their knowledge and confabulated on various new-fangled topics related to the field of Vaccines and Therapeutics.

We would like to convey a great appreciation to following eminent people, honourable guests and Keynote speakers.

• Gabriel Kristian Pedersen, Statens Serum Institut, Denmark
• Carmen Alvarez-Dominguez, Instituto de Investigación Marqués de Valdecilla, Spain
• Frederic J Deschamps, University Hospital of Reims, France
• Randa S Hamadeh, Ministry of Public Health, Lebanon

Special thanks to our Honourable Moderator, Frederic J Deschamps for his remarkable contribution towards smooth functioning at Euro Vaccines 2018 Conference.

Conference series llc Ltd on behalf of the conference congratulates the Best Poster awardees for their outstanding performance and appreciates all the participants who put their efforts in presentations and sincerely wishes them success in future endeavours.

Conference series llc Ltd would like to convey a warm gratitude to Chairs and Co-chairs who contributed effervescently for the smooth functioning of the event, Frederic J Deschamps,University Hospital of Reims, France and Chit Laa Poh, Sunway University, Malaysia.

 Euro Vaccines 2018 conference was a great success with the support of International multi professional steering committee and coordinated by Journal of Vaccines & Vaccination, Journal of Clinical & Cellular Immunology and Immunome Research.

Our sincere thanks to Organizing Committee Members for their gracious presence, support and assistance towards Euro Vaccines 2018 conference, and with the enormous feedback from the participants and supporters of Euro Vaccines 2018, Conference series llc Ltd is glad to announce International Conference on Vaccines and Immune Response June 17-18, 2019 Dubai, UAE.